Log in
Enquire now
‌

US Patent 10179817 Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Patent 10179817 was granted and assigned to CytomX Therapeutics on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10179817
Patent Inventor Names
Jason Gary Sagert0
Luc Roland Desnoyers0
Shweta Singh0
Annie Yang Weaver0
Jonathan Alexander Terrett0
Kimberly Ann Tipton0
Date of Patent
January 15, 2019
Patent Application Number
15146294
Date Filed
May 4, 2016
Patent Citations Received
0
‌
US Patent 11472875 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
‌
US Patent 11046759 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
0
‌
US Patent 11267896 Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
0
‌
US Patent 11692039 Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123
0
‌
US Patent 11352403 Activatable interleukin-2 polypeptides and methods of use thereof
0
‌
US Patent 11802158 Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
‌
US Patent 11859010 Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
0
...
Patent Primary Examiner
‌
Jessica H Roark
Patent abstract

The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10179817 Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us